Insights

All insights

126 items
Conversations
This fall we’ve been sitting down with healthcare experts from across the industry to talk to them about the future of innovation. Today I want to share with you our initial findings from those conversations, as well as a couple of insights about the state of healthcare innovation. 
Read article
Kirsta Hackmeier
Kirsta Hackmeier
7 min read
Explainers
This month, my family and I were affected by two different drug shortages. First, we couldn’t fill a standing prescription for an ADHD drug that a child relies on to function at school. Then, we couldn't source a chemotherapy drug, causing a relative’s urgent cancer treatment to be delayed. 
Read article
Amanda Berra
Amanda Berra
4 min read
Analysis
Why we developed the ‘Board Briefing’ series for members and the general public. 
Read article
Amanda Berra Yulan Egan
Amanda Berra & Yulan Egan
5 min read
Analysis
Cost savings for seniors are real—but there are thousands of ways to squeeze the balloon. 
Read article
Christopher Kerns
Christopher Kerns
11 min read
Analysis
Last month, we kicked off a new research study on the future of innovation. In the weeks that followed, we’ve had many fascinating conversations with industry leaders on the topic. 
Read article
Kirsta Hackmeier
Kirsta Hackmeier
10 min read
Analysis
A State of Healthcare keynote-style presentation is not a good fit for new healthcare learners—and a basic healthcare 101 might not be great either. Instead, consider a ‘market context for our organization’ (and not the solution I drafted first).
Read article
Amanda Berra
Amanda Berra
9 min read
Reports & slides
At Union, we believe strongly in the power of a membership-based model—one that not only provides high-quality content, but also includes the personalized delivery of that content, access to experts, and opportunities to connect with industry peers. 
Read article
Yulan Egan
Yulan Egan
11 min read
Analysis
In April our CEO, Christopher Kerns, kicked off our series on vertical integration with a post on the state of healthcare consolidation—what it looks like today, the promise and perils heralded by supporters and detractors, and a reality check. 
Read article
Kirsta Hackmeier
Kirsta Hackmeier
7 min read
Analysis
For the better part of a decade now, the general industry view on Medicare Advantage has been one of overwhelming positivity. It’s been a steadily growing profit center for legacy plans and providers, and a relatively safe bet for newer market entrants and healthcare investors. 
Read article
Yulan Egan
Yulan Egan
10 min read